Biogen INC BIOGEN INC ORD SHS/ US09062X1037 /
10.09.2024 19:49:21 | Diff. - | Volumen | Geld06:00:08 | Brief06:00:08 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
199,86USD | - | 819 Umsatz: 163.048,87 |
-Geld Vol: - | -Brief Vol: - | 29,23 Mrd.USD | - | 25,02 |
Aktiva
|
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
2023 US GAAP in Mio. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sachanlagen | 3.247,3000 | 3.411,5000 | 3.416,4000 | 3.298,6000 | 3.309,7000 | ||||||
Immaterielle Vermögensgegenstände | 3.527,4000 | 3.084,3000 | 2.221,3000 | 1.850,1000 | 8.363 | ||||||
Finanzanlagen | 1.408,1000 | 772,1000 | 892 | 705,7000 | 0.0000 | ||||||
Anlagevermögen | 18.852,5000 | 17.731,8000 | 16.020,8000 | 14.762,9000 | 19.985,5000 | ||||||
Vorräte | 804,2000 | 1.068,6000 | 1.351,5000 | 1.344,4000 | 2.527,4000 | ||||||
Forderungen | 1.880,5000 | 1.913,8000 | 1.549,4000 | 1.705 | 1.664,1000 | ||||||
Liquide Mitteln | 2.913,7000 | 1.331,2000 | 2.261,4000 | 3.419,3000 | 1.049,9000 | ||||||
Umlaufvermögen | 8.381,8000 | 6.887,1000 | 7.856,5000 | 9.791,2000 | 6.859,3000 | ||||||
Aktiva, gesamt | 27.234,3000 | 24.618,9000 | 23.877,3000 | 24.554,1000 | 26.844,8000 |
Passiva
|
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
2023 US GAAP in Mio. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Verbindlichkeiten aus Lieferungen und Leistungen | 530,8000 | 454,9000 | 589,2000 | 491,5000 | 403,3000 | ||||||
Langfristige Schulden | 4.459 | 7.426,2000 | 6.274 | 6.281 | 6.788,2000 | ||||||
Verbindlichkeiten gegenüber Kreditinstituten | 4.459 | 7.426,2000 | 6.274 | - | - | ||||||
Rückstellungen | 2.882,2000 | 1.174,8000 | 869,2000 | - | - | ||||||
Verbindlichkeiten | 13.895,2000 | 13.932,8000 | 12.917,6000 | 11.165,7000 | 12.045,4000 | ||||||
Gezeichnetes Kapital | ,1000 | ,1000 | ,1000 | ,1000 | ,1000 | ||||||
Eigenkapital | 13.339,1000 | 10.686,1000 | 10.959,7000 | 13.388,4000 | 14.799,4000 | ||||||
Minderheitenanteile | -4,1000 | -14,2000 | 63,5000 | -9,5000 | 0.0000 | ||||||
Passiva, gesamt | 27.234,3000 | 24.618,9000 | 23.877,3000 | 24.554,1000 | 26.844,8000 |
Gewinn- und Verlustrechnung
|
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
2023 US GAAP in Mio. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Umsatzerlöse | 14.377,9000 | 13.444,6000 | 10.981,7000 | 10.173,4000 | 9.835,6000 | ||||||
Abschreibungen (Gesamt) | 680,6000 | 457,2000 | 487,7000 | 518,4000 | 494,8000 | ||||||
Betriebsergebnis | 7.042,6000 | 4.550,1000 | 2.840,7000 | - | - | ||||||
Zinsergebnis | -67,4000 | -180,5000 | -242,6000 | -157,3000 | -29,6000 | ||||||
Ergebnis vor Steuern | 7.125,9000 | 5.047,5000 | 1.745,2000 | 3.591,8000 | 1.296,8000 | ||||||
Ertragsteuern | 1.158 | 992,3000 | 52,5000 | 632,8000 | 135,3000 | ||||||
Gewinnanteil Minderheitsgesellschafter | 0.0000 | 59,9000 | 171,5000 | -85,3000 | ,4000 | ||||||
Konzernjahresüberschuss | 5.888,5000 | 4.000,6000 | 1.556,1000 | 3.046,9000 | 1.161,1000 |
Pro Aktie
Cash Flow
|
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
2023 US GAAP in Mio. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow aus laufender Geschäftstätigkeit | 7.078,6000 | 4.229,8000 | 3.639,9000 | 1.384,3000 | 1.547,2000 | ||||||
Cash Flow aus Investitionstätigkeit | 470,5000 | -608,6000 | -563,7000 | 1.576,6000 | -4.101 | ||||||
Cash Flow aus Finanzierungstätigkeit | -5.860,4000 | -5.272,7000 | -2.086,2000 | -1.747,3000 | 149,3000 | ||||||
Veränderung der liquiden Mittel | 1.688,7000 | -1.651,5000 | 990 | 1.213,6000 | -2.404,5000 | ||||||
Anzahl der Mitarbeiter | 7.400 | 9.100 | 9.610 | - | - |